Prometheus Biosciences Overview
Prometheus Biosciences Target Price
Analysts' 12-month price predictions for RXDX.
Get informed when a big investor buys or sells
+ FollowShare Price
$199.92
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2023-04-16 | Stifel NicolausAnnabel Samimy | $200 |  0% upside |  |
| 2023-01-31 | Goldman Sachs | $144 |  28% downside | |
| 2022-12-08 | OppenheimerJeff Jones | $125 | 37.5% downside | |
| 2022-12-08 | RBC CapitalGregory Renza | $111 | 44.5% downside | |
| 2022-12-08 | BTIGJulian Harrison | $181 | 9.5% downside | |
| 2022-12-08 | Credit SuisseTiago Fauth | $142 | 29% downside | |
| 2022-12-08 | BTIGJulian Harrison | $104.84 | 47.6% downside | |
| 2022-08-28 | Piper SandlerYasmeen Rahimi | $67 | 66.5% downside | |
| 2022-06-10 | Piper SandlerYasmeen Rahimi | $53 | 73.5% downside | |